Abstract:AIM: To observe the change of the ratio of ligand of receptor activator of NF-κB (RANKL) and osteoprotegerin (OPG) by inhibiting the expression RANKL with RNA interference (RNAi), and explore the relationship between osteoblast and osteoclastogenesis. METHODS: The experiment was conducted in the laboratory of Transplantation Immunity of West China Hospital, Sichuan University from May to October 2006. ①Four chemically synthesized small interfering RNA (siRNA) targeting RANKL were transfected into osteoblast using Lipofectamin 2000TM.②RANKL mRNA level was determined by real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR), and the most effective siRNA was screened. ③Three groups including the most effective siRNA transfecting group, negative control group, and blank control group were established and each group involved 5 specimens. Meanwhile, the immunohistochemistry was employed to analyze the expression of RANKL and OPG in osteoblasts, and then the change of ratio of RANKL and OPG was observed. ④The transfected cells of the above three groups and primary rat bone marrow cells were co-cultured to explore the osteoclastogenesis induced by osteoblast. RESULTS: ①The most effective sequence was found out among the 4 candidates. Single dose of siRNA 4 caused nearly 89% loss of RANKL mRNA compared with the blank control group. siRNA1 and siRNA3 reduced the expression of RANKL mRNA to below 50%, and siRNA2 could also efficiently inhibit the expression of RANKL mRNA. ②The positive expressions of RANKL and OPG protein displayed buffy granules which of RANKL were distributed at endochylema and membrane and which of OPG at endochylema. The expression of RANKL protein of siRNA4 transfecting group was lower than that of the blank control group (average integral optical density: 3.05±2.17, 11.31±1.26, respectively), and the differences were significant statistical (P < 0.01); There was no significant difference in the expression of RANKL protein between the negative control group and the blank control group (P > 0.05). And there was no significant difference in the expression of OPG protein among three groups (P > 0.05). The ratio of RANKL/OPG of siRNA4 transfecting group was lower than that of the blank control group (0.12±0.03, 0.45±0.04), and there were obvious differences. ③ The morphous of co-cultured osteoclasts were similar to that of the isolated mature osteoclasts, irregular shape, red-dyed kytoplasm, and pseudopod. The osteoclast number of siRNA4 transfecting group was significantly lower than that of the blank and negative control groups (12±2), (31±7), (28±5) cells per well, P < 0.01, and there was no significant difference between the negative control group and the blank control group (P > 0.05). CONCLUSION: RANKL silenced by RNAi could reduce the ratio of RANKL/OPG and inhibit the formation of osteoclast.

Effects Of Irak-4 Gene Silencing By Sirna On The Mitogen-Activated Protein Kinase Signaling Pathway In Osteoblast-Like Cells

Inhibitory effect of interleukin-1 receptor-associated kinase-4 silencing on mitogen-activated protein kinases expression in human osteoblast-like cells

Effects of IL-1 receptor-associated kinase-4 gene silencing on human osteoblast-like cells.

Effects of IRAK-4 Gene Silencing on Apoptosis in Human Osteoblast-like Cell

In Vitro and in Vivo Killing Effects of Methionine Enkephalin on Osteosarcoma.

IRAK4 Inhibition: an Effective Strategy for Immunomodulating Peri-Implant Osseointegration Via Reciprocally-Shifted Polarization in the Monocyte-Macrophage Lineage Cells

Effect of silencing ligand of receptor activator of NF-kappaB expression by RNA interference on osteoclastogenesis induced by osteoblast

The pro-inflammatory effect of NR4A3 in osteoarthritis

Effects of Receptor Activator of NF-κB Ligand Gene Silencing on the Human Osteoblast-Like MG63 Cells

RNA Interference Targeting p110β Reduces Tumor Necrosis Factor-Alpha Production in Cellular Response to Wear Particles In vitro and Osteolysis In vivo

Effect of Sirna Targeted Against MKK4 on Myostatin-Induced Downregulation of Differentiation Marker Gene Expression.

The Effect of siRNA Targeting RANKL on Osteoclastogenesis Induced by Osteoblast in Vitro

Mir-214 Suppresses the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells and These Effects Are Mediated Through the Inhibition of the JNK and P38 Pathways.

Rna interference targeting p110b reduces tumor necrosis factor-alpha production in cellular response to wear particles in vitro and osteolysis in vivo

The Effects of Interleukin-1Β in Modulating Osteoclast-Conditioned Medium's Influence on Gelatinases in Chondrocytes Through Mitogen-Activated Protein Kinases

Effects and Relationship of ERK1 and ERK2 in Interleukin-1Β-induced Alterations in MMP3, MMP13, Type II Collagen and Aggrecan Expression in Human Chondrocytes.

Effects of Par-4 Gene Silencing Induced by Sirna on the Expression of Smac Gene,activity of Caspase-3,And:Apoptosis of Human Bone Marrow Mesenchymal Stem Cells

[Effects of Small Interfering RNA (sirna) Against Par-4 Gene on the Apoptosis of Human Bone Marrow Mesenchymal Stem Cells].

Effect of siRNA mediated by lentivirus silencing ERK2 on cartilage degeneration in rat models of post traumatic osteoarthritis and its mechanism

Down-Regulation of Tnf-Alpha by Small Interfering Rna Inhibits Particle-Induced Inflammation in Vitro

Overexpression of Microrna-634 Suppresses Survival and Matrix Synthesis of Human Osteoarthritis Chondrocytes by Targeting Pik3r1